The study aims to recruit over 230 glioblastoma patients from 14 NHS hospitals in the UK A major clinical trial in the UK examining
"Sativex"
Jazz Pharma buys GW Pharma for $ 7,2 billion, adding cannabis drug to its portfolio Huge deal: Jazz Pharma acquires
The NHS (National Health Service) has approved the use of Epidiolex and Sativex Thousands of patients will receive treatment based on
NICE and NHS take issue with Sativex and recommend more research on cannabinoids To treat spasticity in people with multiple sclerosis
The UK is the world's largest producer and exporter of medical cannabis according to the UN, while banning its recreational use. UK produced